Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors in patients with colorectal cancer: a retrospective study

中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值作为结直肠癌患者预后因素:一项回顾性研究

阅读:2

Abstract

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been investigated as potential prognostic biomarkers. This study aims to evaluate the association between NLR and PLR with CRC across age groups and assess their prognostic value for overall survival (OS) and cancer-specific survival (CSS). MATERIALS AND METHODS: This is a retrospective study conducted on 285 CRC patients who underwent elective colectomy. Sociodemographic and clinicopathological characteristics were collected from electronic records. Preoperative NLR and PLR were calculated from blood samples. Descriptive analyses, multivariable logistic regression analyses, and survival analyses using Cox regression and Kaplan-Meier tests were used. RESULTS: The highest median NLR was 4.54 and found among the youngest age group (<50 years). High NLR, defined as a value ≥3.19, was associated with worse OS (HR 2.23, p = 0.02) and CSS (HR 2.9, p < 0.05). After adjusting for confounding factors, high NLR remained significantly associated with worse CSS (adjusted HR = 2.89, p = 0.02). PLR did not show any significant associations with OS or CSS. Age, smoking status, and BMI were also independent prognostic factors for OS. CONCLUSION: High NLR was identified as an independent prognostic factor for worse CSS in CRC patients. The association between NLR and PLR with CRC outcomes may vary across different age groups. These findings highlight the potential utility of NLR as a prognostic biomarker in CRC, particularly for CSS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。